Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 3
1980 8
1981 23
1982 35
1983 48
1984 68
1985 80
1986 92
1987 106
1988 93
1989 134
1990 87
1991 96
1992 97
1993 93
1994 88
1995 104
1996 80
1997 82
1998 94
1999 72
2000 48
2001 63
2002 44
2003 38
2004 22
2005 27
2006 30
2007 27
2008 19
2009 16
2010 7
2011 7
2012 10
2013 10
2014 7
2015 7
2016 12
2017 7
2018 3
2019 3
2020 3
2021 4
2022 3
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

1,978 results

Results by year

Filters applied: . Clear all
Page 1
Ranitidine.
Strum WB. Strum WB. JAMA. 1983 Oct 14;250(14):1894-6. JAMA. 1983. PMID: 6312110 Clinical Trial.
Ranitidine is an H2-receptor antagonist that was released recently for use in the treatment of acute duodenal ulcer disease, Zollinger-Ellison syndrome, and systemic mastocytosis with gastric hypersecretion. The pharmacokinetics, efficacy, adverse effects, and clinical uti …
Ranitidine is an H2-receptor antagonist that was released recently for use in the treatment of acute duodenal ulcer disease, Zollinge …
Comparative clinical trial of enprostil and ranitidine in the treatment of gastric ulcer.
Dammann HG, Hüttemann W, Kalek HD, Rohner HG, Simon B. Dammann HG, et al. Am J Med. 1986 Aug 18;81(2A):80-4. doi: 10.1016/s0002-9343(86)80017-1. Am J Med. 1986. PMID: 3092661 Clinical Trial.
In a randomized, double-bind, parallel, multi-clinic study, the safety and efficacy of enprostil (35 micrograms twice daily) and ranitidine (150 mg twice daily) were compared in the treatment of active gastric ulcer in 93 outpatients (47 enprostil-treated patients and 46 …
In a randomized, double-bind, parallel, multi-clinic study, the safety and efficacy of enprostil (35 micrograms twice daily) and ranitidi …
Clinical, controlled trial of somatostatin with ranitidine and placebo in the control of peptic hemorrhage of the upper gastrointestinal tract.
Coraggio F, Bertini G, Catalano A, Scarpato P, Gualdieri L. Coraggio F, et al. Digestion. 1989;43(4):190-5. doi: 10.1159/000199876. Digestion. 1989. PMID: 2575550 Clinical Trial.
We divided the patients into three groups on the basis of the severity of disease (moderate, serious, massive); a subgroup of each group underwent one of the three studied treatments (SST, ranitidine, placebo). After careful clinical and laboratory assessment, we followed …
We divided the patients into three groups on the basis of the severity of disease (moderate, serious, massive); a subgroup of each group und …
Ranitidine and cimetidine in renal transplantation: a clinical trial.
Ahonen J, Paimela H, Kauste A, Häyry P, Eklund B, Pettersson E. Ahonen J, et al. Int J Tissue React. 1983;5(4):373-8. Int J Tissue React. 1983. PMID: 6323338 Clinical Trial.
Sixteen patients were randomized for treatment with ranitidine and seventeen for treatment with cimetidine to prevent the appearance of upper gastrointestinal (UGI) complications after renal transplantation. ...There were, however, significantly more rejection episodes in …
Sixteen patients were randomized for treatment with ranitidine and seventeen for treatment with cimetidine to prevent the appearance …
Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA): A Randomized Clinical Trial.
Florian J, Matta MK, DePalma R, Gershuny V, Patel V, Hsiao CH, Zusterzeel R, Rouse R, Prentice K, Nalepinski CG, Kim I, Yi S, Zhao L, Yoon M, Selaya S, Keire D, Korvick J, Strauss DG. Florian J, et al. JAMA. 2021 Jul 20;326(3):240-249. doi: 10.1001/jama.2021.9199. JAMA. 2021. PMID: 34180947 Free PMC article. Clinical Trial.
In addition, the petitioner proposed that ranitidine could convert to NDMA in humans; however, this was primarily based on a small clinical study that detected an increase in urinary excretion of NDMA after oral ranitidine consumption. ...The findings do not support …
In addition, the petitioner proposed that ranitidine could convert to NDMA in humans; however, this was primarily based on a small cl …
Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
Janiak P, Thumshirn M, Menne D, Fox M, Halim S, Fried M, Brühlmann P, Distler O, Schwizer W. Janiak P, et al. Aliment Pharmacol Ther. 2007 Nov 1;26(9):1259-65. doi: 10.1111/j.1365-2036.2007.03469.x. Aliment Pharmacol Ther. 2007. PMID: 17944740 Free article. Clinical Trial.
NAB was present in eight patients with omeprazole/placebo and six with omeprazole/ranitidine (P = ns) in whom technically adequate gastric pH-studies were obtained (n = 10). The addition of ranitidine had no consistent effect on patient symptoms or quality of life. …
NAB was present in eight patients with omeprazole/placebo and six with omeprazole/ranitidine (P = ns) in whom technically adequate ga …
Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
Madani S, Kauffman R, Simpson P, Lehr VT, Lai ML, Sarniak A, Tolia V. Madani S, et al. J Clin Pharmacol. 2014 Feb;54(2):201-5. doi: 10.1002/jcph.219. Epub 2013 Nov 20. J Clin Pharmacol. 2014. PMID: 24258773 Free article. Clinical Trial.
To characterize and compare acid suppression (pharmacodynamics) and pharmacokinetics of IV famotidine and ranitidine in critically ill children at risk for stress gastritis. ...Twenty-four children randomized to either famotidine (n = 12) or ranitidine (n = 12). Six …
To characterize and compare acid suppression (pharmacodynamics) and pharmacokinetics of IV famotidine and ranitidine in critically il …
Enprostil and ranitidine: comparative efficacy and safety in patients with duodenal ulcer.
Mackinnon M, Alp M, Austad WI, Byrnes D, Cowen A, Duggan J, Pirola R, Thomas M, Ward M. Mackinnon M, et al. Aust N Z J Med. 1987 Jun;17(3):316-20. doi: 10.1111/j.1445-5994.1987.tb01235.x. Aust N Z J Med. 1987. PMID: 3118861 Clinical Trial.
Night-time ulcer pain ceased significantly earlier in the group receiving ranitidine (p = 0.019) and was less severe during the week before the last visit (p = 0.001); daytime pain for ranitidine users was also less severe (p = 0.020) during this week. ...However, t …
Night-time ulcer pain ceased significantly earlier in the group receiving ranitidine (p = 0.019) and was less severe during the week …
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
van der Wouden EJ, Thijs JC, van Zwet AA, Kooy A, Kleibeuker JH. van der Wouden EJ, et al. Am J Gastroenterol. 1998 Aug;93(8):1228-31. doi: 10.1111/j.1572-0241.1998.00400.x. Am J Gastroenterol. 1998. PMID: 9707042 Clinical Trial.
OBJECTIVE: The aim of this study was to compare the efficacy and side effects of 1-wk triple therapy with ranitidine bismuth citrate (RBC) 400 mg b.i.d., clarithromycin 500 mg b.i.d., and metronidazole 500 mg b.i.d., to 2-wk dual therapy with RBC 400 mg b.i.d. and clarithr …
OBJECTIVE: The aim of this study was to compare the efficacy and side effects of 1-wk triple therapy with ranitidine bismuth citrate …
Effervescent and standard formulations of ranitidine--a comparison of their pharmacokinetics and pharmacology.
Watson RG, Johnston BT, Tham TC, Kersey K. Watson RG, et al. Aliment Pharmacol Ther. 1996 Dec;10(6):913-8. doi: 10.1046/j.1365-2036.1996.69240000.x. Aliment Pharmacol Ther. 1996. PMID: 8971288 Clinical Trial.
BACKGROUND: An effervescent formulation of ranitidine may be absorbed faster and achieve a faster onset of action than conventional tablet form. ...METHODS: Fifteen fasting healthy males, aged 18-31 (mean 29) years, were each randomly given, at weekly intervals, 150 mg sta …
BACKGROUND: An effervescent formulation of ranitidine may be absorbed faster and achieve a faster onset of action than conventional t …
1,978 results